5 studies found for:    "Lymphosarcoma"
Show Display Options
Rank Status Study
1 Recruiting FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
Conditions: Lymphoma;   Lymphoma, Non-Hodgkin;   Large B Cell Diffuse Lymphoma
Interventions: Procedure: FLT-PET/CT;   Procedure: FDG-PET/CT;   Drug: FLT
2 Enrolling by invitation Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
Conditions: B-cell Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Diffuse Well-differentiated Lymphocytic Lymphoma;   B Cell Lymphoma;   Follicular Lymphoma,;   Mantle Cell Lymphoma;   Non-Hodgkin's Lymphoma;   Waldenstrom Macroglobulinemia;   Burkitt Lymphoma;   B-Cell Diffuse Lymphoma
Intervention: Drug: PCI-32765
3 Recruiting Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma
Condition: Large B Cell Diffuse Lymphoma
Interventions: Drug: Rituximab;   Procedure: Prophylactic intrathecal chemotherapy
4 Unknown  Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma
Condition: Diffuse Large B-Cell Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Prednisone;   Drug: Doxorubicin
5 Unknown  Targeted Intensification Utilizing ZBEAM Followed by Autologous Stem Cell Transplantation (ASCT) in Patients With High-grade B-Cell Lymphoma
Condition: Lymphoma, Large Cell, Diffuse
Interventions: Drug: ZBEAM (Zevalin, BCNU, Etoposide, Aracytine, Melphalan);   Procedure: ASCT;   Drug: Rituximab

Indicates status has not been verified in more than two years